 |
|
|
| |
Baseline and Week 48 Resistance Analyses in the Phase 3 ARTISTRY-1 Study Evaluating the Bictegravir/Lenacapavir Single-Tablet Regimen
|
| |
| |
IAS 2026 Rio, Brazil
Nicolas Margot, Nina Pennetzdorfer, Vidula Naik, Jairo M Montezuma-Rusca, Peter Sklar, Christian Callebaut
Gilead Sciences, Inc., Foster City, CA, USA
|
| |
|
|
|
|
|
